- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00454454
Virtual Reality Helmet to Test for Problems With Memory (DETECT)
Display Enhanced TEsting for Cognitive Impairment and Traumatic Brain Injury
Study Overview
Status
Conditions
Detailed Description
Since many individuals with mild cognitive impairment (MCI) appear to function normally, MCI may often be recognizable through testing in advance of any changes noticed by family members or caregivers. Early and frequent testing can therefore trigger an earlier diagnosis, which may increase the effectiveness of currently available medications used to delay onset of Alzheimer's symptoms. Primary care and geriatric physicians currently lack the necessary tools required for quick and accurate MCI screening in the doctor's office environment. The current industry-standard is a battery of pen & paper neuropsychological tests that require 1.5 hours in a quiet room with a neuropsychologist.
Comparison: virtual reality display device compared to the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Wesley Woods Health Center
-
Atlanta, Georgia, United States, 30322
- Wesley Woods Outpatient Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 65 yrs of age and older
- MMSE of 18 or greater or mini-cog of 4 or greater
- Ability to read
- Informed consent given
Exclusion Criteria:
- Visual, hearing or physical impairment that would limit ability to use the virtual reality helmet or control device
- Non-English speaking
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
No treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 797-2002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory
-
Kutahya Health Sciences UniversityCompletedWorking Memory | The Working Memory QuestionnaireTurkey
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory, Short-Term | Memory, Long-TermSwitzerland
-
Memorial Sloan Kettering Cancer CenterCompletedMemory Losses | Amnesia-Memory LossUnited States
-
University of Electronic Science and Technology...CompletedOxytocin Effect on Memory Performance During Phase 1 | Oxytocin Effect on Memory Performance During Phase 2 | Oxytocin Effect on Memory Performance During Phase 3 | Oxytocin Effect on Memory Performance During Phase 4China
-
University of Maryland, College ParkUniversity of Massachusetts, AmherstRecruiting
-
Prof. Dominique de Quervain, MDNot yet recruiting
-
University of PennsylvaniaRecruiting
-
University of BaselTerminated
-
Colorado State UniversityInstitute of Cannabis ResearchCompleted
-
University Hospital, GrenobleTIMC-IMAGUnknown